ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.1286C>A (p.Ala429Glu)

dbSNP: rs370412052
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000158427 SCV000208362 uncertain significance not provided 2011-07-31 criteria provided, single submitter clinical testing This variant is denoted Ala429Glu (aka A429E) at the protein level and c.1286 C>A at the cDNA level. The Ala429Glu variant in the MYBPC3 gene has not been reported previously as a disease causing mutation nor as a benign polymorphism, to our knowledge. Ala429Glu results in a non conservative amino acid substitution of a non polar Alanine with a negatively charged Glutamic acid at a residue that is conserved across species. In addition, the Ala429Glu variant was not detected in up to 600 alleles from control individuals of Caucasian and African American ancestry, indicating it is not a common benign variant in these populations. However, data from ethnically matched controls is not available, therefore we cannot evaluate if Ala429Glu may be a population specific benign variant. In summary, with the clinical and molecular information available at this time, we cannot equivocally determine whether the Ala429Glu variant is a disease causing mutation or a rare benign variant. The variant is found in HCM panel(s).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.